Official Title
Faculty of Medicine ,South Valley University
Brief Summary

Ivermectin showed a strong viricidal effect upon covid19 virus in vitro as proved by many authors according to many studies , covid virus stay in postnasal space for 4 days before starting general manifestation, so ivermectin mucoadhesive nanosuspension sprayed inside the nose and post nasal space may help in early management of covid19 and may play a great rule in prophylaxis as well

Detailed Description

150 patient with early covid is devided into two groups first group will receive regular
protocol of drugs second group will receive ivermectin nasal spray in addition to regular
protocl of drugs

Unknown status
COVID19

Drug: intranasal ivermectin spray

usage of ivermectin as intranasal spray for treating early covid patiens

Eligibility Criteria

Inclusion Criteria:

- early covid19 pateints

Exclusion Criteria:

- children and pregnant women

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
Egypt
Locations

Zaky Aref
Qinā, Qina, Egypt

Investigator: Zaky Aref, MD
Contact: 01001771210
doctor.aref@hotmail.com

South Valley University
NCT Number
Keywords
Ivermectin intranasal spray in covid19
MeSH Terms
COVID-19
Ivermectin